Previous 10 | Next 10 |
home / stock / elv / elv articles
Some major U.S. health insurers, including CVS Health Inc (NYSE:CVS), Elevance Health Inc (NYSE:ELV), and Kaiser Permanente wil...
On Monday, The Kroger Company (NYSE:KR) inked a definitive deal to sell its specialty pharmacy business to CarelonRx, a subsidiary of&nbs...
Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years by 8.05% on an annualized basis producing an average annual return of...
Elevance Health (NYSE:ELV) has outperformed the market over the past 20 years by 5.64% on an annualized basis producing an average annual return of...
Elevance Health Inc (NYSE:ELV) posted fourth-quarter 2023 revenues of $42.45 billion, up nearly 7% Y/Y, beating the consensus of $42.09 b...
Elevance Health (NYSE:ELV) has outperformed the market over the past 15 years by 6.39% on an annualized basis producing an average annual return of...
Cigna Group (NYSE: CI) is reportedly in advanced negotiations to divest its Medicare Advantage division and is presently in discussions to sel...
Health Care Service Corporation (HCSC) and Elevance Health Inc (NYSE: ELV) are reportedly engaged in a competitive race to acquire t...
In a recent development in the health insurance sector, Cigna Corporation (NYSE: CI) has withdrawn from its proposed merger with Humana Inc. (...
News, Short Squeeze, Breakout and More Instantly...
Elevance Health Inc Com Company Name:
ELV Stock Symbol:
NYSE Market:
Elevance Health Inc Com Website:
2024-07-17 12:00:27 ET Image source: The Motley Fool. Elevance Health (NYSE: ELV) Q2 2024 Earnings Call Jul 17, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Elevance Health (ELV) Q2 2024 Earnings Call Transcript
Assa Abloy AB ADR (ASAZY) is expected to report for Q2 2024 First Horizon Corporation (FHN) is expected to report $0.37 for Q2 2024 Community Trust Bancorp Inc. (CTBI) is expected to report $1.03 for Q2 2024 Cohen & Steers Inc (CNS) is expected to report for Q2 2024 First Indu...
2Q 2024 operating revenue of $43.2 billion 2Q 2024 adjusted operating gain 1 of $2.8 billion 2Q 2024 diluted EPS 2 of $9.85, up 26%; adjusted diluted EPS 1 of $10.12, up 12% 3Q 2024 dividend of $1.63 per share declared to shareholders Elevance Healt...